000 01124 a2200349 4500
005 20250513003947.0
264 0 _c19811029
008 198110s 0 0 eng d
022 _a0020-8272
024 7 _a10.1159/000468444
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNorman, T R
245 0 0 _aDoxepin plasma levels and anxiolytic response.
_h[electronic resource]
260 _bInternational pharmacopsychiatry
_c1980
300 _a247-52 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnxiety Disorders
_xdrug therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aDoxepin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aTime Factors
700 1 _aBurrows, G D
700 1 _aBianchi, G N
700 1 _aMaguire, K P
700 1 _aWurm, J M
773 0 _tInternational pharmacopsychiatry
_gvol. 15
_gno. 4
_gp. 247-52
856 4 0 _uhttps://doi.org/10.1159/000468444
_zAvailable from publisher's website
999 _c7021105
_d7021105